75 related articles for article (PubMed ID: 1579167)
1. Tetrameric cell-surface MHC class I molecules.
Krishna S; Benaroch P; Pillai S
Nature; 1992 May; 357(6374):164-7. PubMed ID: 1579167
[TBL] [Abstract][Full Text] [Related]
2. Association of class I major histocompatibility heavy and light chains induced by viral peptides.
Townsend A; Ohlén C; Bastin J; Ljunggren HG; Foster L; Kärre K
Nature; 1989 Aug; 340(6233):443-8. PubMed ID: 2666863
[TBL] [Abstract][Full Text] [Related]
3. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody that distinguishes between a phosphorylated, beta 2-microglobulin-associated, and a free, nonphosphorylated, chain of MHC class I.
Thor G; Sepulveda H; Chada S; Dutton RW
J Immunol; 1993 Jul; 151(1):211-24. PubMed ID: 7686933
[TBL] [Abstract][Full Text] [Related]
5. Principles of MHC class I-mediated antigen presentation and T cell selection.
Ljunggren HG; Thorpe CJ
Histol Histopathol; 1996 Jan; 11(1):267-74. PubMed ID: 8720469
[TBL] [Abstract][Full Text] [Related]
6. Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta(2)m as a fusion protein in Escherichia coli.
Ren D; Wang F; He X; Jiang L; Li D; Ying H; Sun S
Protein Expr Purif; 2006 Dec; 50(2):171-8. PubMed ID: 17046278
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin.
Achour A; Michaëlsson J; Harris RA; Ljunggren HG; Kärre K; Schneider G; Sandalova T
J Mol Biol; 2006 Feb; 356(2):382-96. PubMed ID: 16375919
[TBL] [Abstract][Full Text] [Related]
8. Tetramer data reinterpreted.
Benaroch P; Krishna S; Pillal S
Nature; 1993 Mar; 362(6415):23-4. PubMed ID: 8446165
[No Abstract] [Full Text] [Related]
9. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the interactions between MHC class I subunits: a systematic approach for the engineering of higher affinity variants of beta 2-microglobulin.
Shields MJ; Assefi N; Hodgson W; Kim EJ; Ribaudo RK
J Immunol; 1998 Mar; 160(5):2297-307. PubMed ID: 9498770
[TBL] [Abstract][Full Text] [Related]
11. An enhanced and scalable process for the purification of SIV Gag-specific MHC tetramer.
Grimm KM; Trigona WL; Heidecker GJ; Joyce JG; Fu TM; Shiver JW; Keller PM; Cook JC
Protein Expr Purif; 2001 Nov; 23(2):270-81. PubMed ID: 11676602
[TBL] [Abstract][Full Text] [Related]
12. Heterologous cross-linking of Lyt-2 (CD8) to the alpha beta-T cell receptor is more effective in T cell activation than homologous alpha beta-T cell receptor cross-linking.
Boyce NW; Jönsson JI; Emmrich F; Eichmann K
J Immunol; 1988 Nov; 141(9):2882-8. PubMed ID: 3262671
[TBL] [Abstract][Full Text] [Related]
13. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
[TBL] [Abstract][Full Text] [Related]
14. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
15. A semiquantitative rosetting assay for detection of cell-surface class I major histocompatibility complex molecules.
Sigal LJ; Wylie DE
Biotechniques; 1994 Oct; 17(4):776-80. PubMed ID: 7833041
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional structures of MHC class I-peptide complexes: implications for peptide recognition.
Persson K; Schneider G
Arch Immunol Ther Exp (Warsz); 2000; 48(3):135-42. PubMed ID: 10912617
[TBL] [Abstract][Full Text] [Related]
17. Stable expression of MHC class I heavy chain/HLA-DO complexes at the plasma membrane.
van Lith M; van Ham M; Neefjes J
Eur J Immunol; 2003 May; 33(5):1145-51. PubMed ID: 12731039
[TBL] [Abstract][Full Text] [Related]
18. Cross-linking of insulin receptors to MHC antigens in human B lymphocytes: evidence for selective molecular interactions.
Samson M; Cousin JL; Fehlmann M
J Immunol; 1986 Oct; 137(7):2293-8. PubMed ID: 3531328
[TBL] [Abstract][Full Text] [Related]
19. MHC class I surface expression in embryo-derived cell lines inducible with peptide or interferon.
Bikoff EK; Jaffe L; Ribaudo RK; Otten GR; Germain RN; Robertson EJ
Nature; 1991 Nov; 354(6350):235-8. PubMed ID: 1720508
[TBL] [Abstract][Full Text] [Related]
20. DNP-specific/class I MHC-restricted suppressor molecules bear determinants of the T cell receptor alpha- and beta-chains. The V beta 8+ chain dictates restriction to either K or D.
Fairchild RL; Kubo RT; Moorhead JW
J Immunol; 1990 Oct; 145(7):2001-9. PubMed ID: 1697873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
